Active ingredientDapivirineCat. No. P-D015-001CAS 244767-67-7Family · Pharmaceutical analytical standards
Dapivirine
A non-nucleoside HIV reverse transcriptase inhibitor, released from a silicone vaginal ring that is changed every month: in 2020 the European Medicines Agency gave a positive opinion on its use to reduce the risk of HIV in women in developing countries. This family brings together the active ingredient.
Did you know?In 2021 the WHO recommended the ring as an additional prevention option for women at risk: it is flexible, opaque white, 56 millimetres across and comes in a single size.
Go to the active ingredient →Active ingredientDapivirineCat. No. P-D015-001CAS 244767-67-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.